Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Sell Ocugen Stock Before the Other Shoe Finally Drops

By Thomas Niel, InvestorPlace Contributor
The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated.

Contextlogic Might Not Be the Short-Squeeze Candidate You Think It Is

By Josh Enomoto, InvestorPlace Contributor
While the short-squeeze narrative is incredibly enticing for WISH stock, you should think carefully before proceeding any further.

Upstart Nikola Needs The Capital Markets To Keep Going Concerns At Bay

By Tom Kerr, InvestorPlace Contributor
Nikola may produce an interesting and innovative vehicle, but needs ongoing capital for its stock to stay afloat.

Why WKHS Stock Is Running Higher on Wishful Thinking

By Chris Lau, InvestorPlace Contributor
Short-sellers may win in the end by betting against Workhorse, if they wait out the short-lived, speculative buying momentum.

SoFi Is a Bank With the Valuation of a Tech Unicorn

By Ian Bezek, InvestorPlace Contributor
SoFi is building what may become a good business over time. However, the price of SOFI stock is way ahead of the firm's fundamentals.

Canopy Growth Will Continue Losing Money For the Foreseeable Future

By Muslim Farooque, InvestorPlace Contributor
CGC stock continues to lose money, with its rising operational expenses and massive debt burden

Sell AMC Stock Before the Herd Dumps the Shares

By Chris Lau, InvestorPlace Contributor
AMC' stock has stalled in recent days as the buying pressure on it has eased, setting the stage for a potential selloff.

Rocket Companies May Be Facing the Worst of Both Worlds

By Chris Markoch, InvestorPlace Contributor
RKT stock sits below its IPO price.  Is this is an overreaction or a signal that the company may face more than the paper hands of speculative investors?

Churchill Capital IV Isn’t Worth $38 Billion Regardless of Any Valuation

By Stavros Georgiadis, CFA, InvestorPlace Contributor
A $38 billion valuation for Lucid Motors might sound enticing for those considering buying CCIV stock, but is the value really there?

Ocugen Stock Is A Bust After Covaxin’s Emergency Use Rejection

By Muslim Farooque, InvestorPlace Contributor
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts.

AMC Stock Is in for a Return to Earth as Weak Fundamentals Remain

By Joel Baglole, InvestorPlace Contributor
Can movie theatre chain and meme stock favorite AMC Entertainment hold onto its gains? That's the question on investors minds after shares of the Leawood, Kansas-based company have rallied 176% in the past month and now sit at $54.06 a share. A growing number of investors are starting to feel hopeful that the stock can maintain its current level as the summer movie season gets underway.

Get Rid of Ocugen Stock While You Can as the Bad News Piles Up

By Larry Ramer, InvestorPlace Contributor
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares.

Sundial Growers Might Get Its Act Together, but Put Your Money Elsewhere

By Faizan Farooque, InvestorPlace Contributor
SNDL stock is one of the beneficiaries of Reddit’s retail investors piling into cannabis producers, but fundamentals leave you wanting more.

Clover Health Has a Bleak Present and Possibly a Bleaker Future

By Larry Ramer, InvestorPlace Contributor
Given the allegations against Clover Health, CLOV stock poses a great deal of risk. Investors should sell the shares.

MicroVision Seems Like the Honeypot of the Lidar Industry

By Josh Enomoto, InvestorPlace Contributor
MVIS stock might seem like a cheap speculation on the relevant lidar industry but the risk factors are piling up worrisomely.

Don’t Count on a Short Squeeze to Move Clover Health Stock

By Josh Enomoto, InvestorPlace Contributor
Though the short-squeeze idea has credibility with CLOV stock due to high short interest, you don’t want to depend solely on this trick.

Dump Sundial Growers Stock in Favor of Buying Retail Pure-Play Nova Cannabis

By Will Ashworth, InvestorPlace Contributor
Sundial Growers expects its acquisition of Inner Spirit to close in third quarter. Is SNDL stock the best Canadian cannabis retail option?

Reality Should Set-In For Those Buying-Into the BlackBerry Narrative

By Muslim Farooque, InvestorPlace Contributor
BB stock seems unlikely to mount a comeback based on its unclear business model and remarkably weak financial performance

The Bear Case on Clover Health Is Getting More Compelling

By Muslim Farooque, InvestorPlace Contributor
Growing cost of revenues and an unclear path to profitability makes it difficult to invest in CLOV Stock despite its potential
Load More Articles